AIPPI France creates judicial decisions site

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

AIPPI France creates judicial decisions site

The French group of AIPPI has launched a new website containing details of important IP cases in the country

The site, the first to be dedicated to French IP cases, is freely accessible and designed to benefit all AIPPI members, wherever they are based.

Béatrice Thomas, in-house lawyer at RATP and a member of the French group, said the website came about after AIPPI France President Thierry Sueur asked for ideas to build on the 42nd World Congress, which was held in Paris in 2010. Of the three ideas suggested, the creation of a list of important cases was chosen.

“There were two aims behind this project: first, to thank all the participants and not only the French group for their work in Paris, and second to improve our scientific work through better knowledge of each year’s cases,” said Thomas.

The cases are presented in four categories: designs, copyright and unfair competition; trade marks and unfair competition; patents, know-how and unfair competition and general issues. A panel comprising representatives of AIPPI and INPI suggests cases to be included in each category. Professor Michel Vivant of SciencesPo chairs the selection committee.

“We think this process ensures that the decisions chosen are very relevant for international practitioners,” said Denis Monégier du Sorbier of Hoyng Monegier, who worked on the project. He said there are more than 200 decisions in France just in patent cases each year, and many more involving trade marks. The website will be updated twice a year and will include the most important ones.

All the cases are translated into eight other languages, with the translations provided by RWS Group. The site provides a summary of each case, as well as a more detailed document setting out the facts and proceedings, decision, explanation and assessment and a link to the full ruling in French.

“We have already had some reaction and we are interested in AIPPI members’ thoughts,” said Thomas. “We hope to develop the site in the future with more feedback.”

The cases can be seen on AIPPI France’s website at http://www.aippi.fr/fr/focus.


Download the AIPPI Congress News, published by Managing IP from Seoul, Korea, from our conference newspapers page.

more from across site and SHARED ros bottom lb

More from across our site

Evan Lazerowitz, attorney in Robinson + Cole’s bankruptcy and reorganisation group, offers key takeaways for IP interested parties in bankruptcy and insolvency proceedings
While the UK sees heavy IP rankings movement, Germany’s new tiered UPC table signals a shift from early adoption to market maturity
In an exclusive interview, Bernard Ledeboer reveals how a Consolid-backed group of firms wants to expand across Europe, invest in AI and centralise operations to compete at the top tier
Not all private equity firms are the same, so leaders at four externally backed IP firms came together to discuss the frameworks they followed and how they ensured a cultural fit
Top-tier German and Spanish firms are among the advisers on a Europe-wide copyright and licensing tussle concerning the design of the track circuit in Madrid
Partners Alex Wilson and Andreas Kramer say bigger law firm rivals don’t necessarily gain by having a wider jurisdictional reach
VO, which has offices in the Netherlands, Belgium and Germany, is the second European IP firm to secure external backing this week
The Bardehle Pagenberg attorneys-at-law discuss the firm’s Managing IP EMEA Awards 2026 success, Unified Patent Court litigation strategy, and evolving European patent trends
A patent battle between two legal tech companies and a loss for Elon Musk’s xAI against OpenAI were also among the top talking points
With drug prices a hot topic in the US, courts are seemingly more reluctant to prevent the entry of generics to the market
Gift this article